Export 2957 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G. Arendash, Cao, C., Abulaban, H., Baranowski, R., Wisniewski, G., Becerra, L., Andel, R., Lin, X., Zhang, X., Wittwer, D., Moulton, J., Arrington, J., and Smith, A., A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging., J Alzheimers Dis, vol. 71, no. 1, pp. 57-82, 2019.
G. W. Arendash, Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 3, pp. 753-71, 2016.
K. Arfanakis, Evia, A. M., Leurgans, S. E., Cardoso, L. F. C., Kulkarni, A., Alqam, N., Lopes, L. F., Vieira, D., Bennett, D. A., and Schneider, J. A., Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults., J Alzheimers Dis, vol. 73, no. 1, pp. 333-345, 2020.
A. Arighi, Carandini, T., Mercurio, M., Carpani, G., Pietroboni, A. Margherita, Fumagalli, G., Ghezzi, L., Basilico, P., Calvi, A., Scarioni, M., De Riz, M., Fenoglio, C., Scola, E., Triulzi, F., Galimberti, D., and Scarpini, E., Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?, J Alzheimers Dis, vol. 61, no. 1, pp. 47-52, 2018.
A. Arighi, Di Cristofori, A., Fenoglio, C., Borsa, S., D'Anca, M., Fumagalli, G. Giulio, Locatelli, M., Carrabba, G., Pietroboni, A. Margherita, Ghezzi, L., Carandini, T., Colombi, A., Scarioni, M., De Riz, M. Alessandra, Serpente, M., Rampini, P. Maria, Scarpini, E., and Galimberti, D., Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
N. Arispe and De Maio, A., Memory Loss and the Onset of Alzheimer's Disease Could Be Under the Control of Extracellular Heat Shock Proteins., J Alzheimers Dis, vol. 63, no. 3, pp. 927-934, 2018.
J. J. Armstrong, Godin, J., Launer, L. J., White, L. R., Mitnitski, A., Rockwood, K., and Andrew, M. K., Changes in Frailty Predict Changes in Cognition in Older Men: The Honolulu-Asia Aging Study., J Alzheimers Dis, vol. 53, no. 3, pp. 1003-13, 2016.
D. Arnaldi, Donniaquio, A., Mattioli, P., Massa, F., Grazzini, M., Meli, R., Filippi, L., Grisanti, S., Famá, F., Terzaghi, M., Girtler, N., Brugnolo, A., Doglione, E., Pardini, M., Villani, F., and Nobili, F., Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study., J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau., J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team., J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
I. A. C. Arnoldussen, Sundh, V., Bäckman, K., Kern, S., Östling, S., Blennow, K., Zetterberg, H., Skoog, I., Kiliaan, A. J., and Gustafson, D. R., A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older., J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.
B. Arosio, Casati, M., Gussago, C., Ferri, E., Abbate, C., Scortichini, V., Colombo, E., Rossi, P. Dionigi, and Mari, D., Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target., J Alzheimers Dis, vol. 54, no. 2, pp. 417-25, 2016.
I. Arrieta-Cruz, Knight, C. M., and Gutiérrez-Juérez, R., Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism., J Alzheimers Dis, 2015.
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
E. Ma Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia., J Alzheimers Dis, vol. 55, no. 4, pp. 1437-1443, 2017.
D. Asaoka, Xiao, J., Takeda, T., Yanagisawa, N., Yamazaki, T., Matsubara, Y., Sugiyama, H., Endo, N., Higa, M., Kasanuki, K., Ichimiya, Y., Koido, S., Ohno, K., Bernier, F., Katsumata, N., Nagahara, A., Arai, H., Ohkusa, T., and Sato, N., Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial., J Alzheimers Dis, vol. 88, no. 1, pp. 75-95, 2022.
D. Aschwanden, Sutin, A. R., Ledermann, T., Luchetti, M., Stephan, Y., Sesker, A. A., Zhu, X., and Terracciano, A., Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies., J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
E. L. Ashby, Miners, J. S., Kehoe, P. G., and Love, S., Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex., J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.
P. R. Asih, Tegg, M. L., Sohrabi, H., Carruthers, M., Gandy, S. E., Saad, F., Verdile, G., Ittner, L. M., and Martins, R. N., Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier., J Alzheimers Dis, vol. 59, no. 2, pp. 445-466, 2017.
E. Aso, Andrés-Benito, P., and Ferrer, I., Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model., J Alzheimers Dis, vol. 54, no. 3, pp. 903-912, 2016.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
M. Assogna, Motta, C., Bonní, S., Borghi, I., Casula, E. P., Martorana, A., and Koch, G., Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients., J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
B. Atanasova, Mondon, K., Dreyfuss, L., Beaufils, E., Desmidt, T., Hommet, C., El-Hage, W., and Belzung, C., Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals., J Alzheimers Dis, vol. 61, no. 3, pp. 929-938, 2018.
M. Atee, Hoti, K., Parsons, R., and Hughes, J. D., Pain Assessment in Dementia: Evaluation of a Point-of-Care Technological Solution., J Alzheimers Dis, vol. 60, no. 1, pp. 137-150, 2017.
K. J. Atkins, Scott, D., Silbert, B., Pike, K. E., and Evered, L., Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial., J Alzheimers Dis, vol. 83, no. 4, pp. 1637-1649, 2021.